business ๐ฌ Q-Line Biotech IPO: Full Price Concern
Q-Line Biotech is launching its maiden book building IPO for 6253200 equity shares at a price band of Rs. 326 - Rs. 343 per share. The company, which develops and markets diverse reagents, is based in NSE SME and listed on NSE SME Emerge. The IPO runs from May 21, 2026, to May 25, 2026, mobilizing Rs. 214.48 cr at the upper cap. Despite top-line growth, the FY25 bottom line saw a setback due to accounting adjustments and an extraordinary item. Well-informed investors might consider moderate long-term investment given the fully priced nature of the issue. ๐